By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Qbrexza®25.01M40.44%
EmrosiTM14.75M23.84%
Accutane®12.88M20.83%
Foam franchise products (Amzeeq® & Zilxi®)5.86M9.47%
Other / legacy2.74M4.43%
Cutia supply agreement606K0.98%
Royalties on sales of Amzeeq by Cutia13K0.02%
View all
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States and People's Republic of China (PRC)61.86M100.00%